Former Chief Scientific Officer · RELMADA THERAPEUTICS, INC. (RLMD)

Richard Mangano

FY2017 is the first fiscal year CompBrief holds for Richard Mangano as a named executive officer of RELMADA THERAPEUTICS; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2017

$343,186

Salary $303,186Bonus $40,000

1st of 2 named executive officers at Relmada Therapeutics by FY2017 total.

2 named officers on file for RELMADA THERAPEUTICS, FY2017

Richard Mangano’s pay file — $29

  • 1 fiscal year of pay, line by line
  • RLMD’s disclosed peer group of 12 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how RELMADA THERAPEUTICS’s whole pay program stands against its peers

  • RELMADA THERAPEUTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on RLMD→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed January 9, 2019 (DEF 14A).

Free

Get Richard Mangano’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Richard Mangano compensation by year

RELMADA THERAPEUTICS Summary Compensation Table · the one fiscal year held
In US dollars, as RELMADA THERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017
Salary$303,186
Bonus$40,000
Total$343,186

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: RELMADA THERAPEUTICS, INC. DEF 14A filed January 9, 2019, accession 0001213900-19-000461, and prior-year filings. Open the filing on EDGAR.

How this page was built: the RELMADA THERAPEUTICS, INC. filed document, accession 0001213900-19-000461. Every figure is read from that document and cited to the page and table it appears in. Filed January 9, 2019.

RELMADA THERAPEUTICS’s named executive officers, FY2017

as the company reported each
Named executive officerRoleFY2017 total
Richard Mangano · this pageFormer Chief Scientific Officer$343,186
Michael BeckerFormer Chief Financial Officer$186,578

The full RELMADA THERAPEUTICS compensation record

free company brief

This page is one person within RELMADA THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the RELMADA THERAPEUTICS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are RELMADA THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Richard Mangano's compensation dossier · One-time report. No refunds.